Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.36 - $9.25 $665 - $17,103
-1,849 Reduced 31.39%
4,042 $1,000
Q2 2022

Aug 10, 2022

SELL
$0.38 - $1.05 $1,735 - $4,795
-4,567 Reduced 43.67%
5,891 $2,000
Q1 2022

May 16, 2022

BUY
$0.52 - $1.3 $5,438 - $13,595
10,458 New
10,458 $7,000
Q4 2021

Feb 14, 2022

SELL
$0.66 - $1.18 $641 - $1,146
-972 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$1.15 - $1.62 $1,117 - $1,574
972 New
972 $1,000
Q2 2021

Aug 13, 2021

SELL
$1.31 - $2.14 $7,071 - $11,551
-5,398 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$1.85 - $3.04 $1,383 - $2,273
748 Added 16.09%
5,398 $11,000
Q4 2020

Feb 11, 2021

BUY
$1.58 - $2.37 $7,347 - $11,020
4,650 New
4,650 $11,000
Q3 2020

Nov 12, 2020

SELL
$1.86 - $3.15 $1,129 - $1,912
-607 Closed
0 $0
Q2 2020

Jul 31, 2020

BUY
$2.53 - $4.08 $230 - $371
91 Added 17.64%
607 $2,000
Q1 2020

May 01, 2020

SELL
$2.62 - $6.59 $4,011 - $10,089
-1,531 Reduced 74.79%
516 $2,000
Q4 2019

Feb 14, 2020

BUY
$3.34 - $6.19 $5,818 - $10,782
1,742 Added 571.15%
2,047 $13,000
Q3 2019

Nov 14, 2019

SELL
$4.25 - $7.18 $8,415 - $14,216
-1,980 Reduced 86.65%
305 $1,000
Q2 2019

Aug 14, 2019

BUY
$4.76 - $8.1 $9,891 - $16,831
2,078 Added 1003.86%
2,285 $13,000
Q1 2019

May 14, 2019

BUY
$5.15 - $8.53 $1,066 - $1,765
207 New
207 $1,000

Others Institutions Holding HOTH

About Hoth Therapeutics, Inc.


  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.11M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.